Yeshurun M - Search Results

1

Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet) combined morphological and cytogenetical analysis.

Shimoni A, Nagler A, Kaplinsky C, Reichart M, Avigdor A, Hardan I, Yeshurun M, Daniely M, Zilberstein Y, Amariglio N, Brok-Simoni F, Rechavi G, Trakhtenbrot L. Shimoni A, et al. Among authors: yeshurun m. Leukemia. 2002 Aug;16(8):1413-8; discussion 1419-22. doi: 10.1038/sj.leu.2402581. Leukemia. 2002. PMID: 12145678

2

Anti-immunoglobulin-like transcript 3 induced acute myocarditis-A case report.

Itzhaki Ben Zadok O, Shiyovich A, Hamdan A, Yeshurun M, Nardi Agmon I, Raanani P, Kornowski R, Shargian L. Itzhaki Ben Zadok O, et al. Among authors: yeshurun m. Front Cardiovasc Med. 2022 Dec 8;9:1035569. doi: 10.3389/fcvm.2022.1035569. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36568550 Free PMC article.

3

Extracorporeal photopheresis induces NETosis in neutrophils derived from patients with chronic graft-vs-host disease.

Goldberg I, Granot G, Telerman A, Partouche S, Shochat T, Halperin E, Gafter-Gvili A, Shargian L, Yeshurun M, Raanani P, Wolach O, Yahalom V. Goldberg I, et al. Among authors: yeshurun m. J Clin Apher. 2023 Oct;38(5):615-621. doi: 10.1002/jca.22073. Epub 2023 Jul 13. J Clin Apher. 2023. PMID: 37439388

4

CAR-T cell therapy is superior to standard of care as second-line therapy for large B-cell lymphoma: A systematic review and meta-analysis.

Shargian L, Raanani P, Yeshurun M, Gafter-Gvili A, Gurion R. Shargian L, et al. Among authors: yeshurun m. Br J Haematol. 2023 Jan;200(1):e4-e5. doi: 10.1111/bjh.18506. Epub 2022 Oct 25. Br J Haematol. 2023. PMID: 36281746 No abstract available.

5

Listeria monocytogenes Infections in Hematopoietic Cell Transplantation Recipients: Clinical Manifestations and Risk Factors. A Multinational Retrospective Case-Control Study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.

Averbuch D, Tridello G, Wendel L, Itälä-Remes M, Oren I, Karas M, Blijlevens N, Beguin Y, Broers A, Calore E, Cattaneo C, Isaksson C, Robin C, Gadisseur A, Maertens J, De Becker A, Lueck C, Metafuni E, Pichler H, Popova M, Ram R, Yeshurun M, Mikulska M, Camara R, Styczynski J. Averbuch D, et al. Among authors: yeshurun m. Transplant Cell Ther. 2024 Jul;30(7):712.e1-712.e12. doi: 10.1016/j.jtct.2024.04.008. Epub 2024 Apr 15. Transplant Cell Ther. 2024. PMID: 38621480

6

Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey.

Yeshurun M, Rozovski U, Shargian L, Pasvolsky O, van der Werf S, Tridello G, Knelange N, Mikulska M, Styczynski J, Averbuch D, de la Camara R. Yeshurun M, et al. Bone Marrow Transplant. 2023 Apr;58(4):414-423. doi: 10.1038/s41409-023-01916-6. Epub 2023 Jan 18. Bone Marrow Transplant. 2023. PMID: 36653669

7

Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias.

Shimoni A, Kröger N, Zander AR, Rowe JM, Hardan I, Avigdor A, Yeshurun M, Ben-Bassat I, Nagler A. Shimoni A, et al. Among authors: yeshurun m. Leukemia. 2003 Feb;17(2):290-7. doi: 10.1038/sj.leu.2402808. Leukemia. 2003. PMID: 12592325 Clinical Trial.

8

Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity.

Shimoni A, Bielorai B, Toren A, Hardan I, Avigdor A, Yeshurun M, Ben-Bassat I, Nagler A. Shimoni A, et al. Among authors: yeshurun m. Exp Hematol. 2003 May;31(5):428-34. doi: 10.1016/s0301-472x(03)00047-x. Exp Hematol. 2003. PMID: 12763142 Free article.

9

Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma.

Shimoni A, Hardan I, Avigdor A, Yeshurun M, Raanani P, Ben-Bassat I, Nagler A. Shimoni A, et al. Among authors: yeshurun m. Br J Haematol. 2003 Aug;122(3):457-64. doi: 10.1046/j.1365-2141.2003.04446.x. Br J Haematol. 2003. PMID: 12877674 Free article.

10

Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced.

Shimoni A, Yeshurun M, Hardan I, Avigdor A, Ben-Bassat I, Nagler A. Shimoni A, et al. Among authors: yeshurun m. Biol Blood Marrow Transplant. 2004 Jul;10(7):484-93. doi: 10.1016/j.bbmt.2004.03.002. Biol Blood Marrow Transplant. 2004. PMID: 15205669 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters